Sagimet Biosciences Inc. (SGMT) Financials

SGMT Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 263.4 million 7.3 million
March 31, 2026 107.8 million 5.3 million
Dec. 31, 2025 116.5 million 5.1 million
Sept. 30, 2025 128.4 million 9.1 million

SGMT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -10.7 million 3.7 million
March 31, 2026 -8.6 million 1.8 million
Dec. 31, 2025 -11.8 million 1.7 million
Sept. 30, 2025 -10.2 million 1.7 million

SGMT Net Income

No data available :(

SGMT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 240.1 million - 1.9 million
March 31, 2026 104.5 million - 39000
Dec. 31, 2025 113.1 million - 78000
Sept. 30, 2025 116.7 million - 115000

SGMT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 53.1 million
March 31, 2026 32.6 million
Dec. 31, 2025 32.5 million
Sept. 30, 2025 32.5 million

SGMT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 11.5 million 4.3 million -
March 31, 2026 - 7.0 million 4.7 million -
Dec. 31, 2025 - 6.7 million 4.0 million -
Sept. 30, 2025 - 9.7 million 4.6 million -

SGMT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - -
Dec. 31, 2025 - -
Sept. 30, 2025 - -

SGMT

Price: $10.18

52 week price:
4.50
11.15

Earnings Per Share: -1.26 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 657.6 million

Links: